Eli Hurvitz of Teva Pharmaceutical Industries: From pennies to profits - Israel's generic-drug powerhouse may not be large by global pharmaceuticals standards, but it has learned to use every edge it can find.
|Year of Publication:||
|Type of Publication:||Article|
|Title record from database:|| OLC-SSG Economic Sciences|
|Availability:||More access options|
|More options (other):|
|Description not available.|